Needle free injection technology (NFIT)is an extremely broad concept which include a wide range of drug delivery systems that drive drugs through the skin using any of the forces as Lorentz, Shock waves, pressure by gas or electrophoresis which propels the drug through the skin, virtually nullifying the use of hypodermic needle.
Rise in prevalence of diabetes raises the demand for needle-free insulin delivery devices. Asia-Pacific offers lucrative opportunities for the market growth, due to its high population base and growth in awareness about the benefits of needle-free injections and their application in treatment of cancer, diabetes, and other infectious diseases. However, high development costs of needle-free injection systems over traditional needle injection are likely to impede the market growth during the forecast period.
In 2019, the market size of Needle-Free Injectors is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Needle-Free Injectors.
This report studies the global market size of Needle-Free Injectors, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Needle-Free Injectors production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Antares Pharma
Pharma Jet
Bioject Medical Technologies
Medical International Technology
INJEX Pharama
European Pharma Group
PenJet Corporation
Crossject
Market Segment by Product Type
Liquid-based
Projectile/Depot-based
Powder-based
Market Segment by Application
Hospitals & Clinics
Home Care Settings
Research Laboratories
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Needle-Free Injectors status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Needle-Free Injectors manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Needle-Free Injectors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Summary:
Get latest Market Research Reports on Needle-Free Injectors. Industry analysis & Market Report on Needle-Free Injectors is a syndicated market report, published as Global (United States, European Union and China) Needle-Free Injectors Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Needle-Free Injectors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.